FDA 483 - Elegant Direct Corp - November 10, 2021

An FDA inspection of Elegant Direct Corp, a medical device manufacturer in Brooklyn, NY, revealed significant deficiencies in their quality system. The firm was cited for failing to establish written procedures for handling serious injuries and deaths, managing consumer complaints, and implementing corrective and preventive actions for non-conforming medical devices. These observations indicate a fundamental lack of essential operational controls.